Advertisement

Topics

Companies Related to "A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries" [Most Relevant Company Matches] RSS

20:54 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries" found in our extensive corporate database of over 50,000 company records.

Showing "Feasibility Study Surpass Aneurysm Embolization System Intracranial Arteries" Companies 1–25 of 3,600+

Relevant

Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial a...


Three Rivers Medical, Inc.

Three Rivers Medical, Inc. is a privately held medical device company focused on expanding the endovascular management of cerebral aneurysms and stroke. The company manufactures the Rio Embolization Coil System in Mountain View, CA. The Rio Embolization Coil System is not approved for sale in the United States.

Foxhollow Technologies

An estimated 12 million people in the U.S. alone have peripheral arterial disease (PAD). At least 40% of them also suffer from coronary artery disease (CAD). FoxHollow recently launched the SilverHawk® Plaque Excision System, a device that removes the plaque that commonly blocks arteries and interrupts blood flow. Unlike stenting and other methods of opening the artery, the SilverHawk removes the...


PRN Pharmaceutical Research Network

We provide consulting services to pharmaceutical research + development and marketing departments. We focus on clinical trial planning, feasibility of development plans, study design, protocol development, manuscript creation and management, lectures and physician education plans.We provide non-proprietary competitive intelligence and ophthalmic product feasibility assessments to financial and ph...

Cardica

Cardica designs and manufactures proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass graft (CABG) surgery. In CABG procedures, veins or arteries are used to construct alternative conduits to restore blood flow beyond narrowed or occluded portions of coronary arteries, "bypassing" the narrowed or occluded portion of the artery that is impairing blood flow to...

NeuroVasx, Inc.

To develop and commercialize unique technologies and methodologies for the improved treatment and long term care of stroke patients.NeuroVasx, Inc. was founded in 1997 to produce unique diagnostic and therapeutic devices for the neurovascular embolization market. Utilizing unique materials, NeuroVasx's products are intended for the treatment of intracranial aneurysms that, because of their morphol...

MicroVention, Inc.

The Company was founded in April 1997 by Robert Rosenbluth and Brian Cox and incorporated as MicroVention, Inc. in September. MicroVention established the strategic objective of developing and marketing medical devices, which will enable or significantly improve the treatment of diseases in small vessels. Joining the team in December of 1997, Rob Greene brought key neurovascular device experience....

Possis Medical

Possis Medical, Inc. is pioneering mechanical thrombectomy, i.e. the rapid, safe and effective removal of blood clots from native arteries and veins, as well as from synthetic and saphenous vein grafts. The Company currently has a portfolio of three FDA indications for use of its AngioJet® Rheolytic™ Thrombectomy System. The system has been used to treat over 250,000 patients in 1,400 locations...

EnteroMedics Inc.

EnteroMedics is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders. EnteroMedics' proprietary neuroblocking technology, VBLOC® vagal blocking therapy, is designed to intermittently block the vagus nerves using high-frequency, ...

Plextek Limited

Plextek is one of the largest independent electronics design consultancies in Europe. We are situated 10 miles south of Cambridge, UK. Established in 1989 and now with one hundred staff we are one of the leading consultancies in our field. Since our foundation we have been selected by clients with a requirement for high quality custom electronic product and system design. We provide design service...

Vascular Dynamics, Inc.

Vascular Dynamics develops catheter-delivered technologies to bring a better quality of life to patients who are resistant to conventional treatments for hypertension. Vascular Dynamics was one of nine companies chosen in 2012 by the FDA to participate in the Early Feasibility Study IDE Pilot Program. The company is conducting open-label, controlled, multi...

Accuray

Accuray's history began when John R. Adler, MD, professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife® System in 1987 after completing a fellowship in Sweden with Lars Leksell, MD, the founder of radiosurgery. With the CyberKnife System, Adler’s vision was to develop a non-invasive robotic radiosurgery system with superior accuracy for ...

Surgica Corporation

Surgica Corporation manufactures and markets embolization medical devices for the rapidly growing minimally invasive surgical and therapeutic specialties. Embolization is a minimally invasive procedure that can reduce tumors and vascular malformations by closing off the blood vessels that feed them.The procedure is performed by an interventional radiologist, who advances a catheter through the vas...

Aptus Endosystems, Inc

Aptus Endosystems is a privately held medical technology company that has developed advanced technology for the endovascular treatment of aortic aneurysm disease. Founded in 2002, Aptus Endosystems has developed a unique endograft and endovascular stapling system that provides a durable alternative to open surgical repair by separating the functions of ane...

Brain Aneurysm Foundation

Cappella Medical Devices Ltd

Cappella, Inc. is a medical device company that develops novel solutions for the treatment of complex coronary artery disease (CAD) focused on protecting the coronary sidebranch arteries. Cappella’s Sideguard® coronary sidebranch technology offers interventional cardiologists a straightforward, effective, and easy to use solution that preserves the ...

Aptus Endosystems, Inc.

Aptus Endosystems is a privately held medical technology company that has developed advanced technology for the endovascular treatment of aortic aneurysm disease. Founded in 2002, Aptus Endosystems has developed a unique endograft and endovascular stapling system delivered via standard catheter technology. The technology allows surgeons to treat abdominal ...

Medicon A/S

Co-operation with Medicon ensures you a partner with many years’ experience in clinical research.Medicon offers both ARO and CRO services. ARO (Academic Research Organisation) services provide support for your strategic pre-study tasks such as feasibility studies and protocol writing.CRO (Clinical Research Organisation) services take care of all the operational tasks of a clinical trial.

Micrus Endovascular

Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain re...

Endologix

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it ...

Triacle Biocomputing

Triacle Biocomputing is a a spin-off of the biocomputing research group at the University of Oulu (Finland). The firm is legally a single-member company and was founded by Dr. A.H. Juffer in 2001. In 2002-2003, funding from the Tekes organization was obtained to carry out a Feasibility Study on Biocomputing with the objective to identify in greater detail industrial software requirements and to es...

Trial Acceleration Institute, Inc.

Trial Acceleration Institute collaborates with the entire spectrum of clinical trial stakeholders to improve study cycle times. Assisting stakeholders with actionable resolutions to their specific cycle time challenges (from protocol feasibility to patient retention) via the identification and initiation of best-of-class, third-party solutions is the primary mission of Trial Acceleration Institute...

TransPerfect Life Sciences

TransPerfect’s Trial Interactive solution provides a collaborative web-based platform for study start-up and eTMF that enables sponsors, CROs, IRBs, central laboratories, and other vendors to maintain and update clinical trial documentation in a secure online environment. With fully searchable solutions including investigator portals, Trial Interactiv...

Endospan

Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of Aortic Arch Disease including aneurysms and dissections. Endospan has initiated the CE-marking regulatory process to market in Europe the NEXUS™ Stent Graft System, the first endovascular off-the-shelf system to treat Aortic Arch Dise...

ACADIA Pharmaceuticals Inc.

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is currently developing a portfolio consisting of four product candidates including pimavanserin, which is being developed for three separate neurological and psychiatric indi...


More From BioPortfolio on "A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks